Relay Therapeutics RLAY 深 滬
已收盤 10-24 16:00:00 美东时间
6.86
+0.100
+1.48%
華盛通- 最 高7.50
- 今 開6.85
- 成交量 327.71万股
- 最 低 6.77
- 昨 收 6.76
- 總市值 11.80亿
- 52周最高 7.50
- 市盈率 靜 --
- 換手率 1.91%
- 52周最低 1.775
- 委 比 97.97%
- 總股本 1.72亿
- 歷史最高 64.37
- 量 比 1.69
- 振 幅 10.80%
- 歷史最低 1.775
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Goldman's 48 potential M&A candidates
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
09-29 03:14
Guggenheim Assumes Relay Therapeutics at Buy, Announces Price Target of $15
Guggenheim analyst Brad Canino assumes Relay Therapeutics (NASDAQ:RLAY) with a Buy rating and announces Price Target of $15.
09-04 22:10
美股牛股 | 绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%
绩优股狂飙！梅西百货大涨超20%，REV Group涨超12%；房地美ADR涨超16%，美参议院议员敦促特朗普政府暂缓出售公司股份>>
09-04 17:12
HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Lowers Price Target to $14
HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $16 to $14.
08-26 19:12
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
RLAY stock has given up its prior gain. Relay Therapeutics shares were trading higher after the company reported better-than-expected Q2 financial results.
RLAY stock has given up its prior gain. Relay Therapeutics shares were trading ...
08-08 06:51
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Preview: Relay Therapeutics's Earnings
Relay Therapeutics (NASDAQ:RLAY) is preparing to release its quarterly earnings...
08-07 02:09
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
Relay Therapeutics, a clinical-stage precision medicine company combining cutting-edge computational and experimental technologies, will release its second quarter 2025 financial results and corporate updates after U.S. markets close on August 7, 2025. The company, leveraging its Dynamo® platform to target previously intractable protein targets, focuses on small molecule drug discovery in oncology and genetic diseases.
07-31 20:05
